Dekel GelbmanCEO, Board Member
As the founding CEO of FDNA, Dekel Gelbman leads the corporate and business strategy of an innovative digital health company that develops technologies and SaaS platforms used by thousands of clinical, research and lab sites globally in the clinical genomics space. Using the most advanced deep learning and artificial intelligence technologies, FDNA has created a new gold standard – next-generation phenotyping (NGP) – technologies that capture, structure, and analyze complex human physiological data to produce actionable genomic insights from next-generation sequencing data. Since its founding in 2011, FDNA has positioned itself at the forefront of AI, genomics and precision medicine, and is one of the most active and innovative startup companies in this space.
Before FDNA, Mr. Gelbman was a practicing corporate and transactional attorney working for leading law firms, including among others, Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates. Mr. Gelbman’s experience includes working closely with a variety of technology and biotech companies, at all stages – from startups through growth stage companies and to mature, publicly-traded companies. Mr. Gelbman holds an LL.B and an MBA in finance.
Moti ShnibergBoard Chairman
Mr. Shniberg is an innovator, investor, and a serial entrepreneur. He has been key to the success of several global startups and businesses, especially in the sphere of innovative technologies and fast-growing web-based companies such as Face.com (acquired by Facebook) and is an active investor and advisor in other companies such as Outbrain, Hopstop (acquired by Apple), Springmoves, Clarisite and many more. In addition, Mr. Shniberg has a keen interest in the art world and aside from being a collector, he is the Co-founder and Chairman of Artist Pension Trust® (APT), an organization that provides artists with long-term financial security and international exposure and which currently has the largest curated collection of contemporary art in the world and Co-founder and Chairman of MutualArt.com, the largest online art information service, providing historical auction results, the largest archive of art-related articles and information about exhibitions around the world to more than 500,000 registered members.
Dan FaszczykVP of Product
As the VP of Product, Dan manages the company’s product road map, from ideation to execution. Mr. Faszczyk also takes part in the company’s commercial operations based on his more than two decades of experience in business development and entrepreneurship involving medical technologies.
Prior to joining FDNA, Mr. Faszczyk held commercial positions in the healthcare industry at organizations that include J&J, TEVA, Pronto Diagnostics, and KolGene, which he founded and led from inception. Dan holds a BA in accounting and economics from the Hebrew University in Jerusalem, and an MA in political science from the Tel Aviv University.
Peter Krawitz, MDChief Data Science Officer
Dr. Peter Krawitz became FDNA’s Chief Data Science Officer with the goals of identifying and exploring high-impact and original research fields to further the development and use of NGP technologies, as well as driving the research efforts to create new knowledge that serves to expand the field of genetics.
Beyond his role at FDNA, Dr. Krawitz also serves as Director of the Institute for Genomic Statistics and Bioinformatics at the University of Bonn in Germany. Through the use of artificial intelligence in the analysis of big genomic data, his research aims to deepen the understanding of genome biology and advance personalized medicine.
Karen Gripp, MD, FAAP, FACMGChief Medical Officer
Dr. Karen Gripp serves as Chief Medical Officer for FDNA. In this role, she implements her clinical expertise and immense breadth of scientific knowledge to promote FDNA’s NGP technologies and enhance the company’s role as a global leader in clinical genomics.
In addition to her role at FDNA, Dr. Gripp is the Chief of the Division of Medical Genetics at the AI duPont Hospital for Children in Wilmington, DE, and is a Professor of Pediatrics at the S. Kimmel Medical College at T. Jefferson University in Philadelphia, PA. With more than fifteen years of experience, Dr. Gripp is a physician with board certification in pediatrics, clinical genetics, and clinical molecular genetics. Her research interests include RASopathies, craniofacial disorders, novel syndrome delineation, and identification of disease genes.
Karen Madden, Ph.D.Board Observer
Karen is Vice President of Technology and Innovation and is responsible for helping drive innovation across all of PerkinElmer businesses and end markets, including diagnostics, life science, analytical and food. This includes driving collaboration internally and externally – including chairing PerkinElmer’s Technology & Innovation Council, establishing strategic partnerships, and using creative funding mechanisms. Karen is also responsible for identifying new markets, technologies, and innovative, customer driven product offerings – including promoting internal idea generation, championing ideas that cross business, and infusing customer voice into PerkinElmer’s innovation efforts.
Dr. Madden was formerly President of PerkinElmer’s Informatics business, a leading specialized software provider to the scientific research and development market. PerkinElmer Informatics is a leader in electronic laboratory notebooks (ELN) and scientific desktop (ChemDraw) software, as well as analytics and visualization (Spotfire) in scientific research, development and manufacturing markets. Prior to serving as President of the Informatics business, Dr. Madden held various leadership and business development positions within PerkinElmer in the Diagnostic and Emerging Technologies businesses. Dr. Madden joined PerkinElmer in 2010 through an acquisition of VisEn, a molecular imaging company, where she served as Vice President of Business Development and Corporate Development.
Prior to joining VisEn, she was a Director at Feinstein Kean Healthcare and Kendall Strategies, leading business strategy and working with a range of clients from small start-ups to multi-national biopharmaceutical companies conducting business strategy, due diligence, valuation analyses, and qualitative and quantitative market research. Dr. Madden holds a B.A. in Chemistry from Boston University and a M.S. from the University of Pennsylvania. She did her doctoral work in Chemistry at Rutgers University, where she determined the three-dimensional X-ray crystallographic structures of human viruses and viral proteins.
Scientific Advisory Board
Dr. Madhuri HedgePerkinElmer, Inc., Atlanta, GA, USA
Dr. David A. Chitayat, FABMG, FACMG, FCCMG, FRCPCSickKids Hospital, Toronto, Canada
Dr. Chitayat is Professor of Paediatrics, Obstetrics and Gynecology, Laboratory Medicine, Pathobiology and Molecular Genetics and the Medical Director of MSc Program in Genetic Counseling at the University of Toronto. Dr. Chitayat is a fellow of the American Board of Medical Genetics, the Canadian College of Medical Genetics and The Royal College of Physicians and Surgeons of Canada. Dr. Chitayat heads the Prenatal Diagnosis and Medical Genetics Program at Mount Sinai Hospital and is practicing Clinical and Metabolic Genetics in The Hospital for Sick Children. His research interests include Cardiac Genetics, Molecular Genetics and Neurogenetics. Dr. Chitayat has published over 15 book chapters and over 300 peer reviewed papers in these fields. Dr. Chitayat has also been an invited visiting professor, and a keynote speaker at national and international universities and institutions.
Prof. Jill Clayton-Smith, MB ChB, MRCP, FRCPSt Mary's Hospital, Manchester, England
Prof. Clayton-Smith is Consultant Clinical Geneticist at North Western Regional Genetic Service, Honorary Professor in Medical Genetics and Clinical Lead for Research at Saint Mary’s Division/Consultant Manchester Centre for Genomic Medicine at Central Manchester University Hospitals NHS Foundation Trust. Prof. Clayton-Smith is faculty member on several EU teaching courses, runs an annual Manchester Dysmorphology Training course and is the co-organizer of the Syndrome Identification workshops at the annual European Society of Human Genetics Meetings and the International Manchester Dysmorphology Conference. Prof. Clayton-Smith’s major research interests are in genetics of orofacial clefting, syndromic eye disease, Angelman syndrome and related neurodevelopmental disorders, as well as children born to mothers with epilepsy, with particular experience of Fetal Valproate Syndrome. Prof. Clayton-Smith is active in several lay groups including those for Angelman syndrome, Mowat-Wilson Syndrome and NOFAS, National Organisation for Fetal Alcohol Syndrome.
Dr. Cynthia J.R. CurryGenetic Medicine Central California, Fresno, CA, USA
Dr. Curry is Professor of Pediatrics at the University of California, San Francisco and the Medical Director of Genetic Medicine Central California in Fresno, California and on the adjunct clinical faculty at Stanford. She is board certified in Pediatrics and Clinical Genetics and has been practicing clinical genetics in Fresno for over 30 years. Dr. Curry has pursued research studies on thrombophilia, syndrome delineation in the fetus and newborn, and causes of intellectual disability and birth defects. She has held many national positions in both genetics and pediatrics and speaks nationally and internationally.
Prof. Dian Donnai, CBE, FMedSci, FRCPSt Mary's Hospital, Manchester, England
Prof. Donnai is Professor of Medical Genetics in the University of Manchester and Clinical Head of Saint Mary’s Division/Consultant Manchester Centre for Genomic Medicine at Central Manchester University Hospitals NHS Foundation Trust. Prof. Donnai was previously President of the European Society for Human Genetics and was Consultant Advisor in Genetics to the Chief Medical Officer for England, sat on the Government Genetics and Insurance Committee and was president of the Clinical Genetics Society. She was awarded the March of Dimes Lifetime Achievement Award in 2010 and the ESHG Education Award in 2011. She also sits on the Medical and Advisory Boards of a number of patient groups and is a strong advocate for patient involvement in service and research design. Prof. Donnai’s major research interests are in dysmorphology; elucidating the underlying mechanisms of developmental syndromes, and in public engagement in genetics and medicine.
Prof. Mordechai (Motti) Shochat, MDSheba Medical Center, Tel-Hashomer, Israelk
Prof. Shochat is head of the genetic department in Schneider and Rabin Hospitals in Israel, and is a world renowned expert in medical genetics with 248 original research articles to his credit. He has co-authored and edited two books, and received numerous personal awards for his achievements in genetics research. For several decades he has served as professor of pediatrics and medical genetics at Tel Aviv University and Director of the Rafael Recanathi institute for Medical Genetics. Prof. Shochat is a member of the Israeli, American and European Societies of Medical Genetics, as well as of the National Counseling Committee of the Ministry of Health for OB/GYN and Genetics.
Dr. Michael BaraitserLondon Medical Databases, London, England
Dr. Michael Baraitser is the author and co-founder of London Medical Databases. He was formerly Consultant in Clinical Genetics, at Great Ormond Street Children’s Hospital, London. Born in Cape Town, he studied Medicine and Agriculture at the University of Stellenbosch before immigrating to the UK in the early 1970’s. He studied genetics under Prof Cedric Carter and was appointed consultant at the Kennedy Galton Centre, London, before moving back to the Hospital for Sick Children, Great Ormond Street. Dr. Baraitser has co-authored over 300 papers on syndrome recognition and gene identification and several books with the late Prof. Robin Winter.
Vivian J. Weinblatt, MS, CGCArcadia University, Glenside, PA, USA
Ms. Vivian Weinblatt is a certified genetic counselor with over 20 years of clinical experience in multiple settings. She has published book chapters on the topics of genetic counseling and multiple gestations. Ms. Weinblatt previously served as the president of the National Society of Genetic Counselors and the Genetic Counseling Foundation and is currently an adjunct professor at Arcadia University’s Genetic Counseling Program. Ms. Weinblatt obtained her undergraduate degree from Cornell University in Human Development and Family Studies, and her Master’s degree in Genetic Counseling from the University of California, Berkeley. Ms. Weinblatt is certified by the American Board of Medical Genetics, and is a Charter member of the American Board of Genetic Counseling.
Prof. Dr. Gabriele Gillessen-Kaesbach, MDDirector, Institut für Humangenetik, Lubeck, Germany
Dr. Himanshu Goel, MBBS, DM, FRACPUniversity of Newcastle, Newcastle, Australia
Dr. Anna C. E. Hurst, MSUniversity of Alabama, Birmingham, AL, USA
Dr. Hurst is an Assistant Professor of Medical Genetics in the Department of Genetics at the University of Alabama at Birmingham and an adjust faculty member at the HudsonAlpha Institute for Biotechnology. She is a board-certified pediatrician who also trained as a genetic counselor. She is a pediatric clinician for the UAB Undiagnosed Disease Program, skeletal dysplasia clinic, and general genetics. Her clinical interests include dysmorphology, congenital anomaly syndrome delineation, and incorporating phenotypes into the interpretation of genomic sequencing data.
Dr. Valeria Capra, MDIstituto Giannina Gaslini, Genova, Italy
Dr. Annick Raas RothschildSheba Medical Center, Tel-Hashomer, Israel
Annick Raas-Rothschild is a Pediatrician-Medical Geneticist. She is the director of the institute for rare diseases, at the Sheba Medical Center, Tel-Hashomer. She runs a pediatric clinic at the Safra children Hospital [ Sheba Medical Center] for children affected with undiagnosed disorders, and malformations syndromes. Annick is an associate professor at the department of Pediatrics and associate faculty at the department of Human Molecular Genetics and Biochemistry at the Sackler School of medicine, Tel Aviv University, Ramat Aviv. Since 2012, Annick is the country coordinator for Israel at the “Orphanet”, which is a portal for information on rare diseases and orphan drugs. Her research focus on rare diseases including the delineation of new phenotypes [Al Awadi Raas-Rothschild syndrome, Nablus mask-like facial syndrome, glutamate receptor encephalopathy, adaptor complex 4 deficiency syndrome]. She works on the identification of disease-causing genes of rare diseases such as Spondylo-meta-epiphyseal dysplasia with short hands and calcifications due to DDR2 mutations. Her research interests focus also on lysosomal storage diseases [ LSD] such as the gene identification of mucolipidosis II and III, mucolipidosis IV. Since 2001, she has been involved in clinical research linked to new option of treatment of patients affected with LSD’s such as Fabry disease, and mucopolysaccharidosis [MPS].
Dr. Chad Haldeman-EnglertFullerton Genetics Center, Asheville, NC, USA
Dr. Chad Haldeman-Englert is a Clinical Geneticist at the Fullerton Genetics Center in Asheville, NC (USA). He is an adjunct clinical faculty member of the University of North Carolina School of Medicine and the Wake Forest School of Medicine, and is actively involved in teaching genetics to students, residents, and practicing clinicians. He currently serves in leadership of the North Carolina Medical Genetics Association, and is a member of the Education Committee of the American College of Medical Genetics and Genomics. His clinical and research interests are in dysmorphology and multiple congenital anomalies, and he is an active participant at the David W. Smith Workshop and the unknowns session at the annual ACMG meeting. Dr. Haldeman-Englert enjoys incorporating new technologies into the clinical and classroom settings, and was an early subscriber to using facial recognition software in his clinical practice.
Prof. Koen DevriendtUniversity Hospitals Leuven, Belgium
Prof. Devriendt is Professor of Medical Genetics and Embryology at the KU Leuven, and consultant at the Center for Human Genetics at the University Hospitals Leuven, Belgium. He is co-organizer of the annual international European Dysmorphology Meeting in Strasbourg, France. Prof. Devriendt has a special interest in dysmorphololgy, syndromology and genetics of congenital malformations. He is head of the laboratory for Genetics of Human Development, which studies the genetics of congenital malformations and syndromes. He has (co)authored over 400 peer reviewed publications. He actively supports the emerging human genetics community in the DR Congo by providing training and supervising local research projects.
Dr. Omar Abdul-RahmanUniversity of Nebraska Medical Center, Omaha, NE, USA
Omar Abdul-Rahman serves as the Division Director for Medical Genetics in the Department of Pediatrics at the University of Mississippi Medical Center and serves as the founding director for the Center of Genetic Medicine. His clinical practice is focused primarily on pediatric patients at the Batson Children’s Hospital and he also participates in the teaching of genetics to first, second, and third-year medical students with a focus on genetic principles, common genetic conditions, and pharmacogenetics. His background and research interests lie in developing new approaches to systematically capture phenotypic information relevant to clinical genetics, and to apply that information in the context of molecular genetics and genomics so as to reach a mechanistic and diagnostic understanding of health and human disease.
Dr. John Graham, ScDCSMC and Harbor-UCLA Medical Center, Torrance, CA, USA
Dr. John Graham is a pediatrician and medical geneticist, with over 35 years of training and experience in clinical genetics, dysmorphology, teratology, developmental disabilities, communicative disorders, and public health aspects of birth defects. He completed fellowships in developmental disabilities and dysmorphology, and his research involves teratogenic syndromes, genetic syndromes, and other factors that cause birth defects. He holds a Professor of Pediatrics Emeritus Lifetime Appointment at UCLA School of Medicine, where he is on the UCLA Intercampus Medical Genetics Training Program Executive Committee. He continues to treat patients at CSMC and Harbor-UCLA Medical Center. He is an academic clinical geneticist, and his experience covers a wide variety of clinical problems, including craniofacial disorders, growth disorders, birth defects, intellectual disability, genetic conditions, and teratogenic disorders. He currently serves on the Section of Genetics and Birth Defects and the Section of Child Development for the American Academy of Pediatrics. He has served on the Editorial Boards for the following journals: Teratology, Birth Defects Research, American Journal of Medical Genetics, Congenital Anomalies (Japan), Annales de Génétique (France), European Journal of Medical Genetics, Global Pediatric Health, and Clinical Pediatrics. He is a past president of the Teratology Society, where he also served on the Council for many years. He is a past president of the Society for Craniofacial Genetics. He has authored over 240 publications in peer-reviewed journals, as well as over 100 reviews, book chapters and one book. He has been a longstanding and active member of numerous professional organizations and academic societies concerned with the health of children and with the causes and prevention of birth defects, including the American Society of Human Genetics, European Society of Human Genetics, American College of Medical Genetics,
American Academy of Pediatrics, Society for Pediatric Research, American Pediatric Society, Western Society for Pediatric Research, Teratology Society, and the Society for Craniofacial Genetics.
Prof. Martin Zenker, MDInstitute of Human Genetics, University Hospital Magdeburg, Magdeburg, Germany
Dr. Scott McLeanChildren’s Hospital of San Antonio, San Antonio, TX, USA
Dr. Antonio Martinez CarrascalRequena General Hospital, Valencia, Spain
Dr. Martínez Carrascal is Chief of the Pediatric Service in the Requena
General Hospital (Valencia) Spain, since 1993. Member of the Executive
Board of the Spanish Society of Clinical Genetics and
Dysmorphology.(S.E.G.C.D.) Member of the Spanish Collaborative Study of
Congenital Malformations.(E.C.E.M.C.). Member of the Spanish Society of
Pediatric Neurology. (S.E.N.E.P.).
Dr. Brian ChungQueen Mary Hospital, Hong Kong
Dr. Carlos Ferreira, FACMGChildren's National Health System, Washington, D.C.
Dr. Elizabeth RoederChildren's Hospital of San Antonio, San Antonio, TX, USA
Dr. Oana MoldovanCentro Genética Médica St, Maria, Lisbon, Portugal
Dr. Lynne BirdRady Children’s Hospital, San Diego, CA, USA
Dr. Margaret AdamUniversity of Washington, Seattle, WA, USA
Dr. José Elías García-OrtizCIBO, Guadalajara, Mexico
Dr. Matt DeardorffChildren's Hospital of Philadelphia, PA, USA
Dr. Olaf Bodamer, PhD, FACMG, FAAPBoston Children's Hospital, Boston, MA, USA
Prof. Alessandra RenieriUniversità di Siena, Siena, Italy
Dr. Alan BeggsBoston Children's Hospital, Boston, MA, USA
Dr. Pedro SanchezChildren's Hospital of Los Angeles, Los Angeles, CA
Dr. Ronny Kershenovich S.Hospital General de Mexico, Mexico City, Mexico
Born and raised in Mexico City
Studied medicine at Universidad Anahuac school of medicine
Medical specialty in medical genetics at the Hospital General de Mexico.
Certified geneticist from the Mexican Board of Genetics.
Faculty member and professor of genetics in the Instituto Tecnológico de Estudios.
Superiores Monterrey School of Medicine.
Staff member of the Centro Médico ABC (American British Cowdray Medical Center).
Staff member of the Sanatorio Español.
Staff member of the Hospital Infantil Privado Star Medica.
Medical director of Citogen, SC. Cytogenetic Laboratory.
Medical sub director in Genomica, SC Genetics Clinic.
Member of ASHG, ESHG, ACMG.
Special interests are in pediatric genetics and oncology.
Dr. Steven A. SkinnerGreenwood Genetic Center, Greenwood, SC, USA
Dr. Skinner is the Director of the Greenwood Genetic Center. He is a clinical geneticist involved in the evaluation and treatment of children and adults with birth defects, intellectual disabilities, and other genetic disorders. His areas of interest include Rett syndrome, Angelman syndrome, autism, and intellectual disabilities. Dr. Skinner has been actively involved in the treatment initiative of the Center and was instrumental in the development of the South Carolina Center for the Treatment of Genetic Disorders.
Dr. Skinner is certified by the American Board of Medical Genetics (1990) and by the American Board of Pediatrics (1985). He is a Founding Fellow of the American College of Medical Genetics and a Fellow of the American Academy of Pediatrics. He is also a member of the American Society of Human Genetics, the South Carolina Medical Association, the South Carolina Pediatric Society, and the Greenwood County Medical Society.
Dr. John CareyUniversity of Utah, Salt Lake City, UT, USA
Dr. Donald G. BaselChildren's Hospital of Wisconsin, Milwaukee, WI, USA
Dr. June Anne GoldLoma Linda University Medical Center, Loma Linda, CA, USA
Dr. Ghayda MirzaaSeattle Children's Research Institute Center for Integrative Brain Research, Seattle, WA, USA
I am a geneticist and researcher with board certifications in pediatrics, medical genetics, and molecular genetics. The goal of my research is to
investigate the genetic basis of human developmental brain disorders, including brain growth abnormalities, malformations of cortical development,
autism and epilepsy. My work on the PI3K-AKT-MTOR related disorders has led to the identification of several genes within this pathway that cause brain
overgrowth and focal cortical dysplasia (Rivière et al., Nature Genetics 2012; Mirzaa et al., Nature Genetics 2014; Jansen et al., Brain 2015; Mirzaa et
al., Lancet Neurology, 2015; Mirzaa et al., JAMA Neurology, 2016). My current research focuses on identifying the molecular and cellular abnormalities
of developmental brain disorders in affected human neurological tissues, with a special emphasis on the detection of low frequency genetic variation and
pathway dysregulation using high throughput genomic, transcriptomic, and proteomic methods to facilitate molecularly targeted therapeutic trials.
Prof. Alain VerloesHôpital Robert-Debré Ap-Hp, Paris, France
Dr. Andrea Superti-FurgaUniversity of Lausanne, Lausanne, Switzerland
Dr. Arnold MunnichImagine Necker, France
Dr. Ben SolomonGeneDx, Gaithersburg, MD, USA
Dr. Bill DobynsSeattle Children's Hospital, Seattle, WA, USA
Dr. Christina FagerbergOdense University Hospital, Odense, Denmark
Prof. Giovanni NeriIstituto di Genetica Medica Universita Cattolica, Rome, Italy
Dr. Michael HaydenTeva Pharmaceutical Industries, Petah Tikva, Israel
Dr. Miguel del CampoRady Children's Hospital, San Diego, CA, USA
Prof. Poh-San LaiNational University of Singapore, Singapore
Dr. Tinatin TkemaladzeTbilisi State Medical University, Tbilisi, Georgia
Dr. Yuri ZarateArkansas Children's Hospital
Who We Are
Our VISION is to help rare disease patients end their diagnostic odyssey.
Our OBJECTIVE is to make Next-Generation Phenotyping (NGP) a standard of care.
Our MISSION is to disrupt clinical genomics by integrating NGP into the genetic testing workflow.
Our OBSESSION is protecting patient privacy.
Our Core Values
Be aggressive, but realistic with your targets. Work with passion, resolve, and grit. Always aim to over-deliver, rather than over-promise.
Do more with less. Strive to use our resources to the maximum, while being fair to yourself, your team, and your clients.
Cover all your bases. Always validate your assumptions before taking action. Grow through learning.
Be cordial and help your colleagues, while questioning and challenging them. Avoid prodigious, office politics and ego battles at all cost.
Deliver your commitments with excellence and on time. When you are accountable for your commitments, you earn trust from your colleagues and we all earn the trust of our clients.
Voice your opinion when you have it. Show your original thoughts by taking initiatives and by providing constructive feedback.
Be honest, concise, and direct with your communications. Inform your colleagues about both the GOOD and the BAD. Being transparent means being respectful of your coworkers’ time and effort.
Take pride in your work. Celebrate achievements, learn from failures. Have fun and believe in your ability to change the world.